Symbols / ALGN Stock $166.34 +2.86% Align Technology, Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
ALGN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Joseph M. Hogan
Exch · Country NMS · United States
Market Cap 11.91B
Enterprise Value 10.64B
Income 429.89M
Sales 4.10B
FCF (ttm) 538.98M
Book/sh 57.94
Cash/sh 14.80
Employees 20,275
Insider 10d —
IPO Jan 30, 2001
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 27.96
Forward P/E 13.44
PEG 0.88
P/S 2.91
P/B 2.87
P/C —
EV/EBITDA 11.95
EV/Sales 2.60
Quick Ratio 1.17
Current Ratio 1.39
Debt/Eq 2.80
LT Debt/Eq —
EPS (ttm) 5.95
EPS next Y 12.37
EPS Growth 23.90%
Revenue Growth 6.20%
EPS Gr Q/Q 21.00%
Rev Gr Q/Q —
Earnings (next) 2026-07-29
Earnings (prior) 2026-04-29
ROA 7.33%
ROE 10.82%
ROIC —
Gross Margin 70.15%
Oper. Margin 16.59%
Profit Margin 10.50%
Shs Outstand 71.62M
Shs Float 67.02M
Insider Own 6.82%
Instit Own 101.60%
Short Float 7.84%
Short Ratio 4.90
Short Interest 4.92M
52W High 208.31
vs 52W High -20.15%
52W Low 122.00
vs 52W Low 36.34%
Beta 1.70
Impl. Vol. 1.56%
Rel Volume 0.03
Avg Volume 1.15M
Volume 39.29K
Target (mean) $209.07
Tgt Median $214.00
Tgt Low $175.00
Tgt High $240.00
# Analysts 14
Recom Buy
Prev Close $161.71
Price $166.34
Change 2.86%
About

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$209.07
Mean price target
2. Current target
$166.34
Latest analyst target
3. DCF / Fair value
$135.46
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$166.34
Low
$175.00
High
$240.00
Mean
$209.07

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-30 main Evercore ISI Group Outperform → Outperform $220
2026-04-24 main Morgan Stanley Equal-Weight → Equal-Weight $188
2026-04-21 main Piper Sandler Overweight → Overweight $235
2026-04-15 init Citigroup — → Buy $240
2026-03-17 up Barclays Equal-Weight → Overweight $200
2026-02-26 main Barclays Equal-Weight → Equal-Weight $200
2026-02-09 up HSBC Hold → Buy $200
2026-02-05 main Stifel Buy → Buy $210
2026-02-05 main Piper Sandler Overweight → Overweight $220
2026-02-05 main UBS Neutral → Neutral $185
2026-02-05 main Evercore ISI Group Outperform → Outperform $200
2026-02-05 main Wells Fargo Overweight → Overweight $200
2026-02-05 main Morgan Stanley Equal-Weight → Equal-Weight $169
2026-01-20 main Mizuho Outperform → Outperform $200
2025-12-09 init Barclays — → Equal-Weight $170
2025-10-30 main Morgan Stanley Equal-Weight → Equal-Weight $154
2025-10-30 main Evercore ISI Group Outperform → Outperform $170
2025-10-30 main Wells Fargo Overweight → Overweight $181
2025-10-30 reit Piper Sandler Overweight → Overweight $200
2025-10-21 main Morgan Stanley Equal-Weight → Equal-Weight $142
News
RSS: Latest ALGN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-20 LARKIN CHARLES RAYMOND JR Director — 2,326 — —
2026-05-20 MORROW GEORGE J Director — 1,745 — —
2026-05-20 LACOB JOSEPH S Director — 1,745 — —
2026-05-20 CONROY KEVIN T Director — 1,745 — —
2026-05-20 SIEGEL SUSAN E Director — 1,745 — —
2026-05-20 DALLAS KEVIN J. Director — 1,745 — —
2026-05-20 POUL MOJDEH Director — 1,745 — —
2026-05-20 MYONG ANNE Director — 1,745 — —
2026-05-20 SAIA ANDREA LYNN Director — 1,745 — —
2026-05-20 VITALONE BRITT J Director — 1,443 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
4,034.96
+0.90%
3,999.01
+3.54%
3,862.26
+3.42%
3,734.64
Operating Revenue
4,034.96
+0.90%
3,999.01
+3.54%
3,862.26
+3.42%
3,734.64
Cost Of Revenue
1,323.95
+10.34%
1,199.85
+3.85%
1,155.40
+4.95%
1,100.86
Reconciled Cost Of Revenue
1,323.95
+10.34%
1,199.85
+3.85%
1,155.40
+4.95%
1,100.86
Gross Profit
2,711.01
-3.15%
2,799.16
+3.41%
2,706.86
+2.78%
2,633.78
Operating Expense
2,125.70
-0.08%
2,127.39
+3.76%
2,050.21
+3.56%
1,979.73
Research And Development
369.91
+1.57%
364.20
+5.01%
346.83
+13.62%
305.26
Selling General And Administration
1,755.79
-0.42%
1,763.19
+3.51%
1,703.38
+1.73%
1,674.47
Total Expenses
3,449.65
+3.68%
3,327.25
+3.79%
3,205.61
+4.06%
3,080.59
Operating Income
585.31
-12.87%
671.76
+2.30%
656.65
+0.40%
654.05
Total Operating Income As Reported
545.75
-10.18%
607.63
-5.55%
643.34
+0.12%
642.60
EBITDA
822.75
+0.73%
816.80
+2.22%
799.05
+2.46%
779.84
Normalized EBITDA
862.30
-2.11%
880.93
+8.44%
812.37
+2.66%
791.29
Reconciled Depreciation
237.44
+63.71%
145.03
+1.85%
142.40
+13.20%
125.79
EBIT
585.31
-12.87%
671.76
+2.30%
656.65
+0.40%
654.05
Total Unusual Items
-39.56
+38.32%
-64.14
-381.65%
-13.32
-16.27%
-11.45
Total Unusual Items Excluding Goodwill
-39.56
+38.32%
-64.14
-381.65%
-13.32
-16.27%
-11.45
Special Income Charges
-39.56
+38.32%
-64.14
-381.65%
-13.32
-16.27%
-11.45
Other Special Charges
4.18
-86.51%
30.97
—
—
Impairment Of Capital Assets
—
—
—
—
Restructuring And Mergern Acquisition
35.38
+6.66%
33.17
+149.08%
13.32
+16.27%
11.45
Net Income
410.35
-2.61%
421.36
-5.32%
445.05
+23.09%
361.57
Pretax Income
585.29
-3.89%
608.96
-5.03%
641.20
+7.04%
599.06
Net Non Operating Interest Income Expense
16.05
-20.64%
20.22
+17.15%
17.26
+221.56%
5.37
Net Interest Income
16.05
-20.64%
20.22
+17.15%
17.26
+221.56%
5.37
Interest Income Non Operating
16.05
-20.64%
20.22
+17.15%
17.26
+221.56%
5.37
Interest Income
16.05
-20.64%
20.22
+17.15%
17.26
+221.56%
5.37
Other Income Expense
-16.07
+80.65%
-83.02
-153.83%
-32.71
+45.81%
-60.36
Other Non Operating Income Expenses
23.49
+224.36%
-18.89
+2.60%
-19.39
+60.35%
-48.91
Tax Provision
174.94
-6.75%
187.60
-4.36%
196.15
-17.40%
237.48
Tax Rate For Calcs
0.00
-2.98%
0.00
+0.67%
0.00
-22.73%
0.00
Tax Effect Of Unusual Items
-11.82
+40.16%
-19.76
-384.89%
-4.07
+10.16%
-4.54
Net Income Including Noncontrolling Interests
410.35
-2.61%
421.36
-5.32%
445.05
+23.09%
361.57
Net Income From Continuing Operation Net Minority Interest
410.35
-2.61%
421.36
-5.32%
445.05
+23.09%
361.57
Net Income From Continuing And Discontinued Operation
410.35
-2.61%
421.36
-5.32%
445.05
+23.09%
361.57
Net Income Continuous Operations
410.35
-2.61%
421.36
-5.32%
445.05
+23.09%
361.57
Normalized Income
438.08
-5.94%
465.74
+2.52%
454.29
+23.29%
368.49
Net Income Common Stockholders
410.35
-2.61%
421.36
-5.32%
445.05
+23.09%
361.57
Diluted EPS
5.65
+0.53%
5.62
-3.27%
5.81
+26.03%
4.61
Basic EPS
5.66
+0.53%
5.63
-3.26%
5.82
+25.97%
4.62
Basic Average Shares
72.54
-3.12%
74.88
-2.03%
76.43
-2.26%
78.19
Diluted Average Shares
72.59
-3.21%
74.99
-2.06%
76.57
-2.36%
78.42
Diluted NI Availto Com Stockholders
410.35
-2.61%
421.36
-5.32%
445.05
+23.09%
361.57
Earnings From Equity Interest Net Of Tax
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6,233.69
+0.31%
6,214.60
+2.15%
6,083.88
+2.29%
5,947.95
Current Assets
2,616.56
+4.98%
2,492.44
+1.87%
2,446.62
+0.92%
2,424.39
Cash Cash Equivalents And Short Term Investments
1,094.91
+4.89%
1,043.89
+7.31%
972.74
-2.69%
999.58
Cash And Cash Equivalents
1,094.91
+4.89%
1,043.89
+11.36%
937.44
-0.49%
942.05
Cash Equivalents
324.86
+11.46%
291.46
+485.79%
49.76
-78.28%
229.13
Cash Financial
770.05
+2.34%
752.42
-15.24%
887.68
+24.51%
712.92
Other Short Term Investments
—
0.00
-100.00%
35.30
-38.64%
57.53
Receivables
1,157.58
+12.42%
1,029.71
-1.67%
1,047.15
+4.70%
1,000.17
Accounts Receivable
1,101.76
+10.65%
995.68
+10.21%
903.42
+5.09%
859.68
Gross Accounts Receivable
1,135.97
+11.94%
1,014.82
+10.51%
918.32
+5.55%
870.03
Allowance For Doubtful Accounts Receivable
-34.21
-78.84%
-19.13
-28.46%
-14.89
-43.99%
-10.34
Taxes Receivable
55.82
+64.04%
34.03
-76.32%
143.73
+2.31%
140.48
Inventory
226.34
-10.99%
254.29
-14.35%
296.90
-12.35%
338.75
Raw Materials
107.30
-13.73%
124.38
-14.51%
145.49
-15.78%
172.76
Work In Process
65.68
-10.83%
73.66
-19.28%
91.26
-5.49%
96.56
Finished Goods
53.37
-5.12%
56.25
-6.49%
60.15
-13.37%
69.44
Prepaid Assets
62.48
-24.71%
82.98
+58.09%
52.49
-24.07%
69.12
Assets Held For Sale Current
27.98
0.00
—
—
Other Current Assets
47.27
-42.05%
81.58
+5.48%
77.33
+361.37%
16.76
Total Non Current Assets
3,617.13
-2.82%
3,722.16
+2.33%
3,637.26
+3.23%
3,523.56
Net PPE
1,239.78
-10.45%
1,384.51
-1.73%
1,408.86
+4.30%
1,350.73
Gross PPE
2,007.10
-1.91%
2,046.22
+4.42%
1,959.62
+8.84%
1,800.46
Accumulated Depreciation
-767.32
-15.96%
-661.71
-20.14%
-550.76
-22.47%
-449.73
Properties
0.00
0.00
0.00
0.00
Land And Improvements
57.87
-9.40%
63.88
+0.00%
63.88
+8.47%
58.88
Buildings And Improvements
524.61
-0.96%
529.72
+2.35%
517.55
+11.06%
466.00
Machinery Furniture Equipment
272.48
+0.34%
271.57
+9.31%
248.45
+11.18%
223.48
Construction In Progress
127.94
-4.29%
133.68
-45.60%
245.72
-13.84%
285.20
Other Properties
956.79
-2.88%
985.20
+19.88%
821.80
+16.96%
702.66
Leases
67.40
+8.41%
62.17
-0.07%
62.22
-3.15%
64.24
Goodwill And Other Intangible Assets
585.77
+7.26%
546.12
+8.86%
501.65
-0.32%
503.27
Goodwill
491.83
+11.12%
442.63
+5.51%
419.53
+2.94%
407.55
Other Intangible Assets
93.93
-9.23%
103.49
+26.02%
82.12
-14.21%
95.72
Investments And Advances
—
0.00
-100.00%
8.02
-80.89%
41.98
Non Current Deferred Assets
1,513.54
-2.81%
1,557.37
-2.05%
1,590.05
+1.16%
1,571.75
Non Current Deferred Taxes Assets
1,513.54
-2.81%
1,557.37
-2.05%
1,590.05
+1.16%
1,571.75
Other Non Current Assets
278.05
+18.74%
234.16
+81.97%
128.68
+130.51%
55.83
Total Liabilities Net Minority Interest
2,184.55
-7.54%
2,362.61
-3.70%
2,453.39
+4.55%
2,346.59
Current Liabilities
1,920.02
-5.79%
2,038.03
-1.38%
2,066.61
+7.31%
1,925.89
Payables And Accrued Expenses
626.26
-7.33%
675.82
+10.93%
609.25
+9.64%
555.67
Payables
165.50
+5.08%
157.50
+4.15%
151.23
-25.21%
202.19
Accounts Payable
121.45
+11.74%
108.69
-3.92%
113.12
-11.53%
127.87
Current Accrued Expenses
460.76
-11.10%
518.32
+13.16%
458.03
+29.58%
353.48
Total Tax Payable
44.05
-9.75%
48.81
+28.09%
38.10
-48.73%
74.32
Income Tax Payable
44.05
-9.75%
48.81
+28.09%
38.10
-48.73%
74.32
Current Debt And Capital Lease Obligation
31.94
+2.82%
31.06
+4.76%
29.65
+11.58%
26.57
Current Capital Lease Obligation
31.94
+2.82%
31.06
+4.76%
29.65
+11.58%
26.57
Current Deferred Liabilities
1,261.82
-5.21%
1,331.15
-6.76%
1,427.71
+6.26%
1,343.64
Current Deferred Revenue
1,261.82
-5.21%
1,331.15
-6.76%
1,427.71
+6.26%
1,343.64
Total Non Current Liabilities Net Minority Interest
264.53
-18.50%
324.59
-16.08%
386.78
-8.06%
420.70
Long Term Debt And Capital Lease Obligation
82.51
-6.47%
88.21
-9.03%
96.97
-3.35%
100.33
Long Term Capital Lease Obligation
82.51
-6.47%
88.21
-9.03%
96.97
-3.35%
100.33
Tradeand Other Payables Non Current
68.20
-29.30%
96.47
-17.37%
116.74
-6.15%
124.39
Other Non Current Liabilities
113.82
-18.64%
139.91
-19.16%
173.06
-11.69%
195.97
Stockholders Equity
4,049.15
+5.12%
3,851.99
+6.10%
3,630.49
+0.81%
3,601.36
Common Stock Equity
4,049.15
+5.12%
3,851.99
+6.10%
3,630.49
+0.81%
3,601.36
Capital Stock
0.01
+0.00%
0.01
+0.00%
0.01
-12.50%
0.01
Common Stock
0.01
+0.00%
0.01
+0.00%
0.01
-12.50%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
71.36
-3.36%
73.85
-1.63%
75.08
-2.84%
77.27
Ordinary Shares Number
71.36
-3.36%
73.85
-1.63%
75.08
-2.84%
77.27
Additional Paid In Capital
1,509.60
+10.82%
1,362.23
+17.22%
1,162.14
+11.22%
1,044.95
Retained Earnings
2,464.16
-0.79%
2,483.77
+1.50%
2,447.17
-4.66%
2,566.69
Gains Losses Not Affecting Retained Earnings
75.39
+1161.09%
5.98
-71.76%
21.17
+305.83%
-10.28
Other Equity Adjustments
75.39
+1161.09%
5.98
-71.76%
21.17
+305.83%
-10.28
Total Equity Gross Minority Interest
4,049.15
+5.12%
3,851.99
+6.10%
3,630.49
+0.81%
3,601.36
Total Capitalization
4,049.15
+5.12%
3,851.99
+6.10%
3,630.49
+0.81%
3,601.36
Working Capital
696.55
+53.28%
454.41
+19.58%
380.01
-23.77%
498.50
Invested Capital
4,049.15
+5.12%
3,851.99
+6.10%
3,630.49
+0.81%
3,601.36
Total Debt
114.45
-4.05%
119.28
-5.80%
126.62
-0.23%
126.91
Capital Lease Obligations
114.45
-4.05%
119.28
-5.80%
126.62
-0.23%
126.91
Net Tangible Assets
3,463.38
+4.76%
3,305.87
+5.66%
3,128.84
+0.99%
3,098.09
Tangible Book Value
3,463.38
+4.76%
3,305.87
+5.66%
3,128.84
+0.99%
3,098.09
Available For Sale Securities
—
—
8.02
-80.89%
41.98
Investmentin Financial Assets
—
0.00
-100.00%
8.02
-80.89%
41.98
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
593.22
-19.64%
738.23
-6.05%
785.78
+38.16%
568.73
Cash Flow From Continuing Operating Activities
593.22
-19.64%
738.23
-6.05%
785.78
+38.16%
568.73
Net Income From Continuing Operations
410.35
-2.61%
421.36
-5.32%
445.05
+23.09%
361.57
Depreciation Amortization Depletion
237.44
+63.71%
145.03
+1.85%
142.40
+13.20%
125.79
Depreciation
—
—
—
—
Depreciation And Amortization
237.44
+63.71%
145.03
+1.85%
142.40
+13.20%
125.79
Other Non Cash Items
77.43
+52.74%
50.69
-23.00%
65.84
-8.31%
71.81
Stock Based Compensation
185.87
+7.00%
173.70
+12.78%
154.03
+15.49%
133.37
Provisionand Write Offof Assets
—
—
—
—
Asset Impairment Charge
5.07
+186.12%
-5.88
-217.94%
4.99
0.00
Deferred Tax
33.09
+28.46%
25.76
+238.16%
-18.64
+52.80%
-39.49
Deferred Income Tax
33.09
+28.46%
25.76
+238.16%
-18.64
+52.80%
-39.49
Operating Gains Losses
—
—
—
—
Gain Loss On Investment Securities
—
—
—
—
Change In Working Capital
-356.01
-391.51%
-72.43
-817.80%
-7.89
+90.64%
-84.31
Change In Receivables
-139.91
+8.85%
-153.49
-46.72%
-104.61
-585.47%
21.55
Changes In Account Receivables
-139.91
+8.85%
-153.49
-46.72%
-104.61
-585.47%
21.55
Change In Inventory
0.81
-96.77%
25.05
-16.96%
30.17
+123.19%
-130.10
Change In Prepaid Assets
13.43
-80.11%
67.53
+232.37%
-51.01
+22.13%
-65.51
Change In Payables And Accrued Expense
-118.59
-272.91%
68.58
+122.30%
30.85
+120.28%
-152.14
Change In Accrued Expense
-95.65
-206.63%
89.70
+93.63%
46.33
+137.99%
-121.94
Change In Payable
-22.93
-8.58%
-21.12
-36.49%
-15.47
+48.75%
-30.20
Change In Account Payable
5.33
+732.27%
-0.84
+89.06%
-7.70
+78.91%
-36.52
Change In Other Working Capital
-111.76
-39.50%
-80.11
-192.38%
86.71
-64.15%
241.89
Investing Cash Flow
-112.44
+55.89%
-254.91
-30.09%
-195.94
+8.14%
-213.32
Cash Flow From Continuing Investing Activities
-112.44
+55.89%
-254.91
-30.09%
-195.94
+8.14%
-213.32
Net PPE Purchase And Sale
-102.44
+11.36%
-115.58
+34.96%
-177.72
+39.12%
-291.90
Purchase Of PPE
-102.44
+11.36%
-115.58
+34.96%
-177.72
+39.12%
-291.90
Capital Expenditure
-102.44
+11.36%
-115.58
+34.96%
-177.72
+39.12%
-291.90
Net Investment Purchase And Sale
0.00
-100.00%
43.85
-25.03%
58.49
-37.17%
93.10
Purchase Of Investment
0.00
0.00
+100.00%
-2.91
+89.61%
-28.00
Sale Of Investment
0.00
-100.00%
43.85
-28.58%
61.40
-49.30%
121.10
Net Business Purchase And Sale
-10.00
+94.55%
-183.42
-138.21%
-77.00
-525.80%
-12.30
Purchase Of Business
-10.00
+94.55%
-183.42
-138.21%
-77.00
-525.80%
-12.30
Net Other Investing Changes
—
0.23
-15.47%
0.28
+112.57%
-2.21
Financing Cash Flow
-464.58
-30.60%
-355.72
+40.55%
-598.34
-19.27%
-501.69
Cash Flow From Continuing Financing Activities
-464.58
-30.60%
-355.72
+40.55%
-598.34
-19.27%
-501.69
Net Issuance Payments Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
-444.19
-35.59%
-327.60
+42.10%
-565.76
-38.37%
-408.89
Common Stock Payments
-465.94
-32.04%
-352.88
+40.43%
-592.36
-36.16%
-435.04
Repurchase Of Capital Stock
-465.94
-32.04%
-352.88
+40.43%
-592.36
-36.16%
-435.04
Net Other Financing Charges
-20.39
+27.50%
-28.12
+13.66%
-32.58
+64.90%
-92.80
Changes In Cash
16.20
-87.31%
127.60
+1599.91%
-8.51
+94.18%
-146.27
Effect Of Exchange Rate Changes
35.02
+265.58%
-21.15
-552.86%
4.67
+140.57%
-11.51
Beginning Cash Position
1,044.96
+11.34%
938.52
-0.41%
942.36
-14.34%
1,100.14
End Cash Position
1,096.19
+4.90%
1,044.96
+11.34%
938.52
-0.41%
942.36
Free Cash Flow
490.78
-21.18%
622.65
+2.40%
608.06
+119.65%
276.83
Income Tax Paid Supplemental Data
134.75
-23.90%
177.08
-39.88%
294.57
+27.03%
231.88
Change In Income Tax Payable
-28.27
-39.38%
-20.28
-160.92%
-7.77
-222.84%
6.33
Change In Tax Payable
-28.27
-39.38%
-20.28
-160.92%
-7.77
-222.84%
6.33
Common Stock Issuance
21.75
-13.97%
25.28
-4.94%
26.59
+1.71%
26.15
Earnings Losses From Equity Investments
—
—
—
—
Issuance Of Capital Stock
21.75
-13.97%
25.28
-4.94%
26.59
+1.71%
26.15
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category